MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes (Q26773451)

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Modulation of double-stranded RNA-activated protein kinase in insulin sensitive tissues of obese humans.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Islet-associated macrophages in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Nutrient regulation of the mTOR complex 1 signaling pathway

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The pro- and anti-inflammatory properties of the cytokine interleukin-6.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Evolution of the unfolded protein response.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Shared principles in NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Pattern recognition receptors and inflammation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

https://api.crossref.org/works/10.1530%2FEJE-15-1065

1 reference

7 January 2021

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

mTOR signaling in growth control and disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Differential scales of protein quality control

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Distinct Roles for JNK and IKK Activation in Agouti-Related Peptide Neurons in the Development of Obesity and Insulin Resistance.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Endoplasmic reticulum stress plays a central role in development of leptin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

NF-κB, inflammation, and metabolic disease.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

TNF-alpha and adipocyte biology

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Endoplasmic reticulum stress, obesity and diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

TOR, a central controller of cell growth

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Inflammation and endoplasmic reticulum stress in obesity and diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Gene-specific control of inflammation by TLR-induced chromatin modifications

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Inflammasomes in health and disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Endocrine disruptors in the etiology of type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Type 2 diabetes mellitus--an autoimmune disease?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Nutrient sensing and inflammation in metabolic diseases

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Adipokines in inflammation and metabolic disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Signal integration in the endoplasmic reticulum unfolded protein response

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Molecular mechanisms of mTOR-mediated translational control

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

mTOR: from growth signal integration to cancer, diabetes and ageing

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

IL-6 biology: implications for clinical targeting in rheumatic disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Atypical protein kinase C in insulin action and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Insulin gene mutations as a cause of permanent neonatal diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Characterization of double-stranded-RNA-activated kinase that phosphorylates alpha subunit of eukaryotic initiation factor 2 (eIF-2 alpha) in reticulocyte lysates

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Inflammation of the hypothalamus leads to defective pancreatic islet function.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Chaperone insufficiency links TLR4 protein signaling to endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

PROPHYLACTIC FOOT TREATMENT IN PATIENTS WITH DIABETES MELLITUS: ANALYSES OF ITS EFFECT ON THE PREVENTION OF INFECTION OF THE LOWER EXTREMITIES AND THE OPERATIVE PROGNOSIS IN A SERIES OF FIVE HUNDRED SEVENTY-SIX CASES.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Transmetatarsal Amputation for Infection or Gangrene in Patients with Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Dietary risk factors for development of childhood obesity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Obesity, insulin resistance and free fatty acids

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The IKK complex, a central regulator of NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Diversity of the human intestinal microbial flora

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Linking long-term dietary patterns with gut microbial enterotypes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Insulin Deficiency and Insulin Inefficiency

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Immunological and inflammatory functions of the interleukin-1 family

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Inflammatory mechanisms in obesity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The biology and medical implications of interleukin-6.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Saturated fatty acids do not directly stimulate Toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

THE NATURE OF THE LOWERED RESISTANCE TO INFECTION IN DIABETES MELLITUS.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

IMMUNITY IN DIABETES. III. RELATION OF TISSUE GLYCOGEN AND BLOOD CHEMISTRY TO BACTERIAL DISSEMINATION, ANTIBODY FORMATION AND SURVIVAL AFTER INFECTION IN DIABETES.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Pharmacogenetics of metformin response: a step in the path toward personalized medicine

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Insulin sensitivity: modulation by nutrients and inflammation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

TLRs and innate immunity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Protein kinase Ctheta expression is increased upon differentiation of human skeletal muscle cells: dysregulation in type 2 diabetic patients and a possible role for protein kinase Ctheta in insulin-stimulated glycogen synthase activity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases insulin gene expression via up-regulation of orphan nuclear receptor small heterodimer partner

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

TLR4 expression in bone marrow-derived cells is both necessary and sufficient to produce the insulin resistance phenotype in diet-induced obesity.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The role for endoplasmic reticulum stress in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

TLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The Epidemic of Obesity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Initiation and execution of lipotoxic ER stress in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

The role of IRE1alpha in the degradation of insulin mRNA in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Stress kinases in the modulation of metabolism and energy balance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Pancreatic inflammation and increased islet macrophages in insulin-resistant juvenile primates

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Increased number of islet-associated macrophages in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Assessing the human gut microbiota in metabolic diseases

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Turning off a viral/lipid sensor improves type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Salsalate improves glycemia and inflammatory parameters in obese young adults

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-1065

7 January 2021